3rd Quarter - Report

JOHNS HOPKINS UNIVERSITY for JOHNS HOPKINS UNIVERSITY

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Global Health issues

LobbyistCovered position, as disclosed
CHRISTOPHER AUSTIN —

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO)

Immigration IMM

DACA

LobbyistCovered position, as disclosed
KRISTEN REEK —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES

Defense DEF

H.R. 2810 NDAA for FY2018 CDMRP language in Senate NDAA; Cybersecurity

LobbyistCovered position, as disclosed
CHRISTOPHER AUSTIN —
KRISTEN REEK —

Contacted: Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE

Bills named: H.R. 2810 (115th)

Taxation/Internal Revenue Code TAX

Tax Reform

LobbyistCovered position, as disclosed
BETH ANN FELDER —
MELISA LINDAMOOD —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ)

Economics/Economic Development ECN

Tech Transfer

LobbyistCovered position, as disclosed
BETH ANN FELDER —

Contacted: Agency for Healthcare Research & Quality (AHRQ); SENATE; Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

H.R. 1628 American Health Care Act; CMS regulatory reform; Drug prices; 340B; Maternal Infant Early Childhood Home visiting; Opioid Epidemic; CDC and FTC Health Research; Substance Use Records Sharing; CMMI; Maryland waiver; CAPABLE; Emerging issues in patient safety; Cancer treatments; Public Health issues

LobbyistCovered position, as disclosed
CHRISTOPHER AUSTIN —
BETH ANN FELDER —
MELISA LINDAMOOD —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE

Bills named: H.R. 1628 (115th)

Budget/Appropriations BUD

FY18 appropriations; Scientific research funding; Education funding; F&A costs; NIH funding; Injury Control Research Centers funding; Teen Pregnancy Prevention Program funding; Health Careers Opportunity Program funding; Fetal Tissue research language.

LobbyistCovered position, as disclosed
CHRISTOPHER AUSTIN —
BETH ANN FELDER —
KRISTEN REEK —

Contacted: Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Government Accountability Office (GAO); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.